On August 4, Hamilton Lane (NASDAQ:HLNE) posted a first fiscal quarter that showed just how far the private markets manager has scaled. Revenue jumped 56% year over year to $275.3 million, fee-related earnings climbed 49% to $124.5 million, and the firm’s total asset footprint pushed past $1.1 trillion. That kind of quarter would normally be the whole story. Instead, it came wrapped around three separate balance sheet payouts and a candid admission that client flows have gotten choppier than the headline numbers suggest.
Growth Firing On All Fronts
Hamilton Lane’s specialized funds are doing the heavy lifting. Fee-earning assets under management in that category grew 25% year over year to $42.6 billion, and that mix shift toward higher-fee products pushed the blended fee rate up to 69 basis points. Management and advisory fees rose 21% to $161.4 million, and FRE margin expanded to 53% from 51% a year earlier, a sign the extra revenue is reaching the bottom line rather than getting absorbed by costs.
The Evergreen platform, Hamilton Lane’s semi-liquid product line built for individual and smaller institutional investors, generated $640 million of net inflows and ended the quarter with $19 billion in assets. Ten of twelve funds took in net new money, and none of them needed to gate redemptions even as the broader alternatives industry has wrestled with liquidity questions. The company also added six senior Evergreen sales professionals poached from Fidelity, BlackRock, PIMCO, JPMorgan, Morgan Stanley and Monroe Capital, and just landed its multi-strategy equity fund on a third wirehouse platform.
Fundraising on the closed-end side was equally strong. The sixth direct equity fund closed at $3.8 billion combined, 57% larger than its predecessor, while the seventh secondary fund and second venture fund each held first closes, at $1.3 billion and $370 million. On top of that, Hamilton Lane is set to book roughly $33 million in combined gains from monetizing its stakes in Russell Investments and Canoe, on top of a newly public stake in Securitize.
Cracks Beneath The Surface
Not every part of the story is clean. Hamilton Lane’s non-US multi-strategy equity fund swung to net outflows for the quarter, and management pointed to a broader hesitancy taking hold. Co-CEO Erik Hirsch acknowledged “a slowdown in flows on certain products and the general hesitancy with investors,” a rare moment of candor from a company that otherwise leaned on strong numbers.
The redemptions in that non-US fund partly reflect success. Investors who put a dollar in at inception have seen it grow to $2.32, and some are simply harvesting gains or shifting capital into separately managed accounts. Still, an outflow is an outflow, and it shows that even Hamilton Lane’s most seasoned Evergreen products are not immune to the caution running through the alternatives industry right now.
Growth is also getting more expensive to produce. Total expenses rose 50% year over year, with compensation and benefits up 55% as the firm added headcount and paid out on stronger performance. Customized separate account fee-earning assets grew just 2% year over year, the slowest pace of any segment, as older accounts wind down and fee step-downs offset new business. None of that derails the growth story, but it’s a reminder that scaling a platform this large isn’t free.
What Wall Street Is Watching
Hedge fund interest in Hamilton Lane rose from 30 funds holding a position to 35, which points to accumulating institutional conviction. Short sellers disagree, with short interest sitting at 10.19% of the float, a level that signals real skepticism rather than routine hedging. Shares trade at a forward P/E of 14.45 as of September 3, a modest multiple that doesn’t look like it’s pricing in the kind of growth the company just reported. That gap between rising fund ownership, heavy short interest and an undemanding multiple is the tension investors are sitting with.
Where The Story Goes Next
Hamilton Lane’s quarter shows a business generating fee growth, margin expansion and multiple sources of cash from its balance sheet all at once. For the growth case to keep playing out, Evergreen inflows need to outrun redemptions like the one in the non-U.S. equity fund, and the newly hired sales team needs to convert its pedigree into distribution wins. For the caution to be warranted, the flow slowdown Hirsch flagged would need to spread beyond one product and into the specialized funds now driving most of the fee growth.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Follow Insider Monkey on Google News.